Medical Device Business And India's Changing Role
Trends and Challenges
Managing Director, Amritt Inc., USA
Indian companies fare in the dynamic environment?
of Indian work for leading Multinational Companies
for Innovations in Medical Technology in their R & D
operations in India. These scientists and Engineers
are doing “world class work”.
they work for multinationals, their talents are
available in India.
California, the leaderships and R & D manpower of
the Medical Device Companies comprise of Indian
Talent in a big way. People of Indian Origin are
rare resource and creators of Intellectual Property
(IP) for their Companies.
the capability of India for Innovations and ability
to create value for the day-to-day requirements
(like T. B. Diagnostics), it is possible to find
such solutions right in India and for this market is
not limited to India, (but could be extended to)
Africa, Latin America, Middle East etc.
opportunities are far bigger and far more immediate
and hence it is better for Indian Companies to look
at them rather than waiting for Government of India
to change this rule or that rule.
to work with Global minds. We need to have more
“Tata Nano's coming out from the Medical Device
success coming only from Innovative Companies,
focused on manufacturing.
“Taiwan” and “Korea” has done in Electronics, Indian
Companies can do for medical device market globally
and create far more value and far more market
capitalization than what we have seen till today.
tremendous value in creating Intellectual Property
which in the long run would serve India very well.
Abstract of Presentation made by Mr Gunjan Bagla
during the 10th National Conference on Indian
Medical Device & Plastic Disposable Industry 2013
at Ahmedabad is given below.
Gunjan Bagla, the India Business Consultant, has
25 years of global sourcing, engineering, and
marketing experience. He has held senior positions
in technology sales and marketing. He is the
founder and Managing Director of Amritt, Inc. and
his clients include Johnson & Johnson, Raytheon,
Covidien, Clorox, Roche and Paramount Farms,
Gunjan is the author of the acclaimed title "Doing
Business in 21st Century India: How to Profit
Today from tomorrow’s most exciting Market"
published in 2008 by Warner/Hachette Books. He
created the executive seminar " Business with
India" for Caltech, the California Institute of
Technology, Pasadena, California. In November
2010, Gunjan was the only Southern California
business person to accompany President Obama as
part of the Executive Mission to India. For his
expertise on India, Gunjan has been interviewed on
Fox Business Television, BBC World News, BBC
Television's The Hub with Nik Gowing and National
Public Radio's To The Point with Warren Olney.
He's been quoted in in the Harvard Business
Review, the New York Times, the Los Angeles Times,
Business Week , Industry Week, and the Hollywood
Reporter, for his expertise on India.
Gunjan serves on the board of the South Asia
Studies Association. He is a mechanical
engineering graduate of the Indian Institute of
Technology and immediate past president of the IIT
Alumni Group Pan IIT USA. Gunjan completed his MBA
from Southern Illinois University, where he was
inducted into the Beta Gamma Sigma honor society.
He also blogs at
Regulatory, Market and Cost Pressures are transforming
the global medical device industry. Impending changes
in American healthcare payments systems, accentuate
the pressures in the boardrooms at any company who is
dependent on American revenues. At the same time the
demands of the next “2 billion people” beyond the
developed countries are an opportunity and a
challenge. How will Indian companies fare in the
are the opportunities for medical device engineers in
India to collaborate with or compete with their
“Trends & Challenges
in Global Medical Device Business and India’s Changing
Elaborating on the
above, Mr Gunjan Bagla explained the following :
motivated to know more and understand the current
scenario on “Innovations In Indian Medical Device
Industry ” after his first visit to Sree Chitra
Tirunal Institute Of Medical Sciences about 7 years
Indian Companies V/s Indian Engineers : are not
necessarily same. “People of Indian work for leading
Multinational Companies for Innovations in Medical
Technology in their R & D operations in India. These
scientists and Engineers are doing “world class
work”. Though they work for multinationals, their
talents are available in India. These people are not
going to work for those companies for their entire
lives. Compared to 20 years ago, India now has
access to such talents.